Thermo Fisher Scientific Inc. (NYSE: TMO) has completed its previously-announced acquisition of Ahura Scientific Inc., a Wilmington, Mass.-based developer of optical systems for the detection of unknown and suspect substances. The deal was valued at $145 million in cash, plus an undisclosed amount of earnouts based on 2010 financial milestones. Ahura Scientific had raised nearly $30 million, from firms like ARCH Venture Partners, Castile Ventures, Fuse Capital (fka ComVentures) and GF Private Equity.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its previously announced acquisition of Ahura Scientific, a leader in handheld Raman and FT-IR (Fourier-transform infrared) spectroscopy instruments that are used worldwide in the identification of chemicals for safety, security and pharmaceutical applications. Ahura generated full-year 2009 revenues of approximately $45 million. The company will be integrated into Thermo Fisher’s Analytical Technologies Segment.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.